Volume 25, Number 3—March 2019
Research
Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017
Figure 1
![Countries participating in a multicenter study of Cronobacter sakazakii infections in humans, Europe, 2017. Dark green indicates the 8 countries that sent C. sakazakii isolates to the study center in Austria; light green indicates the 3 countries where historical outbreaks were detected; and red indicates the 13 countries that participated but did not provide isolates. AT, Austria; BE, Belgium; BG, Bulgaria; CH, Switzerland; CY, Cyprus; CZ, Czech Republic; DE, Germany; DK, Denmark; ES, Spain; FR](/eid/images/18-1652-F1.jpg)
Figure 1. Countries participating in a multicenter study of Cronobacter sakazakii infections in humans, Europe, 2017. Dark green indicates the 8 countries that sent C. sakazakii isolates to the study center in Austria; light green indicates the 3 countries where historical outbreaks were detected; and red indicates the 13 countries that participated but did not provide isolates. AT, Austria; BE, Belgium; BG, Bulgaria; CH, Switzerland; CY, Cyprus; CZ, Czech Republic; DE, Germany; DK, Denmark; ES, Spain; FR, France; GR, Greece; HR, Croatia; IE, Ireland; IT, Italy; LV, Latvia; NL, Netherlands; NO, Norway; PL, Poland; PT, Portugal; RO, Romania; RS, Serbia; SE, Sweden; SI, Slovenia; UK, United Kingdom.
1Members of the EUCRONI study group are listed at the end of this article.